Mammotome Elite
Payments companies reported to CMS as associated with Mammotome Elite. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mammotome Elite, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mammotome Elite
These are the largest totals companies reported as associated with Mammotome Elite. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Susan Boolbol | Poughkeepsie, NY | Surgery | $5,304.00 |
| Michael Berry | Germantown, TN | Surgical Oncology | $5,304.00 |
| Terri Gizienski | Pittsburgh, PA | Diagnostic Radiology | $654.00 |
| Christine Ormsby | Festus, MO | Diagnostic Radiology | $436.00 |
| Matthew Miller | Pittsburgh, PA | Diagnostic Radiology | $365.00 |
| Hannah Kotch | Livingston, NJ | Diagnostic Radiology | $365.00 |
| Hanadi Bu-Ali | Wauwatosa, WI | Surgery | $310.00 |
| Ronda Henry Tillman | Little Rock, AR | Surgical Oncology | $161.00 |
| Amanda Mendiola | Akron, OH | Surgery | $161.00 |
| Kaye Lu | Mountain View, CA | Surgery | $161.00 |
Prescribed Mammotome Elite?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.